Search - tctmd.com

Displaying 61 - 80 of 108

Sort: Relevancy | Date

News Daily News

Immediate, Midterm Outcomes Encouraging for Bioresorbable Scaffolds in STEMI

Todd Neale

November 17, 2014

News Conference News ESC 2014

IBIS-4: High-Dose Statin Therapy May Reverse Atherosclerosis in STEMI

Todd Neale

September 02, 2014

News Conference News ESC 2014

Another Strike Against Thrombectomy in 1-Year TASTE Results

Todd Neale

September 02, 2014

News Daily News

In-Hospital Switching of Antiplatelet Agents in MI Patients Relatively Common, Driven by Patient Risk, Other Factors

L.A. McKeown

August 20, 2014

News Daily News

Autopsy Study Identifies Lesion, Procedural Traits Linked to Early Stent Thrombosis

April 23, 2014

Presentation

Intracoronary Thrombolysis in STEMI Patients with Massive Intraluminal Thrombus, Failed Aspiration

Presenter: Daniella Boscarelli

April 10, 2014

News Daily News

STEMI Patients with Large Thrombus Benefit from Low-dose Thrombolysis

Yael L. Maxwell

April 10, 2014

Presentation

Intracoronary Stem Cell Infusion After Acute MI: A Meta-analysis and Update on Clinical Trials

Presenter: R. de Jong

April 08, 2014

News Daily News

Meta-analysis: Bone Marrow Mononuclear Cell Therapy Fails to Show Efficacy in Acute MI

Yael L. Maxwell

April 08, 2014

News Daily News

Meta-analysis: PCI Adds No Benefit to Medical Therapy in Patients with Proven Ischemia

Yael L. Maxwell

December 08, 2013

Presentation TCT 2013

Case #1: Management of Residual Thrombus After Intracoronary Administration of Abciximab and Manual Thromboaspiration in STEMI.

Presenter: Alejandro Fernandez

October 29, 2013

News Daily News

INFUSE-AMI: Thirty-Day Reduction in Infarct Size May Translate to 1-Year Benefit

Caitlin E. Cox

October 11, 2013

News Daily News

Baseline White Blood Cell Count Predicts Infarct Size in Anterior STEMI

Yael L. Maxwell

September 27, 2013

Presentation

Impact of Intracoronary Bone Marrow Cell Therapy on LV Function in the Setting of STEMI

Presenter: Ronak Delewi

September 16, 2013

News Conference News ESC 2013

PROMISE: Intracoronary Adenosine Effective in STEMI Patients with Shorter Ischemic Times

September 03, 2013

News Daily News

REOPEN-AMI Published: Adenosine Reduces ‘No-Reflow’ in STEMI Patients

July 05, 2013

News Daily News

REOPEN-AMI Publicado: La Adenosina Reduce la ‘Ausencia de Reflujo’ en Pacientes STEMI

July 05, 2013

News Daily News

STEMI Marked by Microvascular Dysfunction Linked to Higher Long-term Mortality

Jason Kahn

June 28, 2013

News Daily News

Las Células Madre de la Médula Ósea No son Efectivas Antes ni Después de sufrir un IAM

Jason Kahn

April 26, 2013

News Daily News

Bone Marrow Stem Cells Not Effective Early or Late After AMI

Jason Kahn

April 26, 2013

Advertisement

Immediate, Midterm Outcomes Encouraging for Bioresorbable Scaffolds in STEMI

IBIS-4: High-Dose Statin Therapy May Reverse Atherosclerosis in STEMI

Another Strike Against Thrombectomy in 1-Year TASTE Results

In-Hospital Switching of Antiplatelet Agents in MI Patients Relatively Common, Driven by Patient Risk, Other Factors

Autopsy Study Identifies Lesion, Procedural Traits Linked to Early Stent Thrombosis

Intracoronary Thrombolysis in STEMI Patients with Massive Intraluminal Thrombus, Failed Aspiration

STEMI Patients with Large Thrombus Benefit from Low-dose Thrombolysis

Intracoronary Stem Cell Infusion After Acute MI: A Meta-analysis and Update on Clinical Trials

Meta-analysis: Bone Marrow Mononuclear Cell Therapy Fails to Show Efficacy in Acute MI

Meta-analysis: PCI Adds No Benefit to Medical Therapy in Patients with Proven Ischemia

Case #1: Management of Residual Thrombus After Intracoronary Administration of Abciximab and Manual Thromboaspiration in STEMI.

INFUSE-AMI: Thirty-Day Reduction in Infarct Size May Translate to 1-Year Benefit

Baseline White Blood Cell Count Predicts Infarct Size in Anterior STEMI

Impact of Intracoronary Bone Marrow Cell Therapy on LV Function in the Setting of STEMI

PROMISE: Intracoronary Adenosine Effective in STEMI Patients with Shorter Ischemic Times

REOPEN-AMI Published: Adenosine Reduces ‘No-Reflow’ in STEMI Patients

REOPEN-AMI Publicado: La Adenosina Reduce la ‘Ausencia de Reflujo’ en Pacientes STEMI

STEMI Marked by Microvascular Dysfunction Linked to Higher Long-term Mortality

Las Células Madre de la Médula Ósea No son Efectivas Antes ni Después de sufrir un IAM

Bone Marrow Stem Cells Not Effective Early or Late After AMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content